+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pet Contraceptive Vaccine Market - Global Forecast 2026-2032- Product Image
Pet Contraceptive Vaccine Market - Global Forecast 2026-2032- Product Image
Sale

Pet Contraceptive Vaccine Market - Global Forecast 2026-2032

  • Report

  • 186 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6134350
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Pet Contraceptive Vaccine Market is projected to reach USD 368.99 Million in 2026. It is expected to continue growing at a CAGR of 7.48%, reaching USD 567.32 Million by 2032.

Pet Contraceptive Vaccines: Executive Summary Scope

Pet contraceptive vaccines represent an emerging approach to managing reproduction in companion animals through immune-mediated mechanisms rather than conventional surgical procedures or routine hormonal administration. The field sits at the intersection of veterinary medicine, animal welfare, reproductive biology, immunology, and population management. Evaluation should distinguish between laboratory development, veterinary authorization, clinical evidence, owner acceptance, and practical deployment, because progress in one area does not automatically establish broad clinical use.

Shifts Reshaping Veterinary Reproductive Management

Veterinary reproductive management is being influenced by demand for less invasive options, growing attention to animal welfare, and the need for responsible control of unwanted litters. Pet contraceptive vaccines may become relevant where surgery is difficult to access, recovery time is a concern, or temporary fertility management is preferred. However, product development must address duration of effect, reversibility, species-specific safety, dosing schedules, reproductive-health monitoring, and owner understanding of treatment limitations. Regulatory expectations for clinical evidence and post-treatment surveillance remain central to adoption.

How Artificial Intelligence Could Accelerate Development and Use

Artificial intelligence can support this field by helping researchers analyze immune-response data, identify candidate antigens, model dose-response relationships, and prioritize safety questions for laboratory investigation. In clinical settings, data-driven tools may assist with patient selection, treatment reminders, adverse-event surveillance, and interpretation of reproductive-health records. These applications require representative veterinary datasets, transparent validation, cybersecurity controls, and professional oversight. AI-generated predictions should complement-not replace-veterinary examination, informed consent, and regulatory review.

Regional Insights Across Veterinary and Animal-Welfare Systems

North America is characterized by established companion-animal healthcare infrastructure and active discussion of non-surgical reproductive control. Latin America may see relevance where access to sterilization services varies substantially between urban and rural areas, although affordability and delivery capacity are important constraints. Europe’s emphasis on welfare, traceability, and evidence-based veterinary practice places strong weight on safety, reversibility, and regulatory compliance. The Middle East includes diverse veterinary systems and pet-ownership patterns, requiring locally appropriate education and service models. Africa’s priorities may include access, population management, and integration with broader animal-health programs. Asia-Pacific combines advanced veterinary markets with highly diverse regulatory, cultural, and service environments, making country-specific implementation essential.

Group-Level Signals from ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN members may benefit from coordinated veterinary education and adaptable delivery models that reflect varied regulatory capacity and pet-care access. BRICS economies present substantial diversity in research capabilities, animal-health systems, and affordability, making harmonized evidence standards and local manufacturing capabilities potentially important. The European Union places particular emphasis on common regulatory principles, welfare safeguards, and consistent evidence requirements across member states. G7 countries generally have mature clinical research and veterinary infrastructures, supporting rigorous evaluation while maintaining high expectations for safety and transparency. GCC markets may require service models aligned with varied import, licensing, and veterinary-practice frameworks. NATO is not a veterinary regulatory bloc, but its member-country coverage includes diverse animal-health systems where preparedness, logistics, and public-sector coordination can influence access to veterinary technologies.

Country-Level Considerations for Product Development and Adoption

Australia’s geographically dispersed communities make distribution, follow-up, and rural veterinary access important considerations. Brazil and Mexico may require delivery models that address regional differences in veterinary capacity and affordability. Canada and the United States have sophisticated companion-animal care systems, but adoption would depend on clinical evidence, professional guidance, and regulatory authorization. China, India, Japan, and South Korea combine significant companion-animal populations with distinct regulatory, cultural, and clinical environments, requiring localized evidence and communication. France, Germany, Italy, Spain, and the United Kingdom place strong emphasis on veterinary standards, animal welfare, and informed use. Russia’s adoption environment would likewise depend on domestic regulatory pathways, veterinary infrastructure, and access to validated products.

Strategic Priorities for Veterinary and Animal-Health Leaders

Industry leaders should prioritize well-designed, species-appropriate clinical studies that measure efficacy, duration, reversibility, fertility outcomes, and short- and long-term safety. Development programs should engage veterinarians, regulators, shelters, breeders, and pet owners early to clarify acceptable use cases and communication needs. Practical plans should include cold-chain or storage requirements, administration training, follow-up protocols, adverse-event reporting, and clear guidance on whether and when repeat treatment is appropriate. Leaders should also avoid positioning vaccination as a universal replacement for sterilization and should invest in independent welfare assessment, transparent evidence disclosure, and equitable access strategies.

Research Methodology for Assessing the Pet Contraceptive Vaccine Field

A robust assessment combines structured review of peer-reviewed veterinary and immunology literature, regulatory publications, clinical-trial records, animal-welfare guidance, and publicly available technical documentation. Evidence should be screened by species, intervention mechanism, development stage, study design, endpoint quality, duration of follow-up, and reported safety outcomes. Geographic analysis should compare regulatory conditions, veterinary-service capacity, cultural context, and access considerations across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific, while separately considering ASEAN, BRICS, the European Union, G7, GCC, and NATO groupings. Country interpretation should cover Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Russia, South Korea, Spain, the United Kingdom, and the United States without treating group membership as proof of market readiness.

Conclusion: Evidence and Responsible Implementation Are Decisive

Pet contraceptive vaccines offer a potentially valuable addition to companion-animal reproductive management, but their practical significance depends on validated safety, dependable duration, clear reversibility expectations, regulatory acceptance, and veterinary confidence. Regional and country differences will shape access, education, and service delivery, while AI may improve research efficiency and clinical monitoring when governed responsibly. The strongest path forward is evidence-led development that places animal welfare, informed owner choice, professional oversight, and transparent post-treatment surveillance at the center of implementation.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Pet Contraceptive Vaccine Market, by Animal Type
7.1. Introduction
7.2. Cats
7.2.1. Indoor Cats
7.2.2. Outdoor Cats
7.3. Dogs
8. Pet Contraceptive Vaccine Market, by Product Type
8.1. Introduction
8.2. Hormonal
8.2.1. Injectable
8.2.2. Oral
8.3. Non-Hormonal
8.3.1. DNA-Based
8.3.2. Protein-Based
9. Pet Contraceptive Vaccine Market, by Distribution Channel
9.1. Introduction
9.2. Online Pharmacies
9.3. Retail Pharmacies
9.4. Veterinary Clinics
10. Pet Contraceptive Vaccine Market, by End User
10.1. Introduction
10.2. Animal Shelters
10.3. Pet Owners
10.4. Veterinary Hospitals
11. Pet Contraceptive Vaccine Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Pet Contraceptive Vaccine Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Pet Contraceptive Vaccine Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Boehringer Ingelheim International GmbH
15.2. Ceva Santé Animale S.A.
15.3. Elanco Animal Health Incorporated
15.4. Hester Biosciences Limited
15.5. HIPRA, S.A.
15.6. Merck & Co., Inc.
15.7. SenesTech, Inc.
15.8. Vetoquinol S.A.
15.9. Virbac S.A.
15.10. Zoetis Inc.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Pet Contraceptive Vaccine Market, Years Considered for the Study
FIGURE 2. Global Pet Contraceptive Vaccine Market, Research Design
FIGURE 3. Global Pet Contraceptive Vaccine Market, Research Framework
FIGURE 4. Global Pet Contraceptive Vaccine Market, Data Triangulation
FIGURE 5. Global Pet Contraceptive Vaccine Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Pet Contraceptive Vaccine Market Size, by Animal Type, 2025 vs 2032 (%)
FIGURE 7. Global Pet Contraceptive Vaccine Market Size, by Animal Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Pet Contraceptive Vaccine Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 9. Global Pet Contraceptive Vaccine Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 11. Global Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Pet Contraceptive Vaccine Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Pet Contraceptive Vaccine Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Pet Contraceptive Vaccine Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Pet Contraceptive Vaccine Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Pet Contraceptive Vaccine Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Pet Contraceptive Vaccine Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Pet Contraceptive Vaccine Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Pet Contraceptive Vaccine Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Pet Contraceptive Vaccine Market Segmentation & Coverage
TABLE 2. Global Pet Contraceptive Vaccine Market Size, 2017-2032 (USD Million)
TABLE 3. Global Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 4. Global Cats Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Cats Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Cats Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Indoor Cats Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Indoor Cats Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Indoor Cats Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Outdoor Cats Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Outdoor Cats Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Outdoor Cats Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Dogs Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Dogs Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Dogs Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 17. Global Hormonal Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Hormonal Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Hormonal Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Injectable Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Injectable Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Injectable Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Non-Hormonal Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Non-Hormonal Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Non-Hormonal Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global DNA-Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global DNA-Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global DNA-Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Protein-Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Protein-Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Protein-Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 36. Global Online Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Online Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Online Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Veterinary Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Veterinary Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Veterinary Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 46. Global Animal Shelters Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Animal Shelters Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Animal Shelters Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Pet Owners Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Pet Owners Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Pet Owners Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Veterinary Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Veterinary Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Veterinary Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Pet Contraceptive Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Asia-Pacific Pet Contraceptive Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Asia-Pacific Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 58. Asia-Pacific Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
TABLE 59. Asia-Pacific Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 60. Asia-Pacific Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
TABLE 61. Asia-Pacific Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 64. North America Pet Contraceptive Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. North America Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 66. North America Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
TABLE 67. North America Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 68. North America Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
TABLE 69. North America Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
TABLE 70. North America Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 71. North America Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 72. Latin America Pet Contraceptive Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Latin America Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 74. Latin America Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
TABLE 75. Latin America Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 76. Latin America Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
TABLE 77. Latin America Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
TABLE 78. Latin America Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 79. Latin America Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 80. Europe Pet Contraceptive Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Europe Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 82. Europe Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
TABLE 83. Europe Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 84. Europe Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
TABLE 85. Europe Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
TABLE 86. Europe Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 87. Europe Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 88. Middle East Pet Contraceptive Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Middle East Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 90. Middle East Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
TABLE 91. Middle East Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 92. Middle East Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
TABLE 93. Middle East Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
TABLE 94. Middle East Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 95. Middle East Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 96. Africa Pet Contraceptive Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Africa Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 98. Africa Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
TABLE 99. Africa Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 100. Africa Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
TABLE 101. Africa Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
TABLE 102. Africa Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 103. Africa Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 104. Global Pet Contraceptive Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. ASEAN Pet Contraceptive Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. ASEAN Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 107. ASEAN Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
TABLE 108. ASEAN Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 109. ASEAN Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
TABLE 110. ASEAN Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
TABLE 111. ASEAN Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 112. ASEAN Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 113. GCC Pet Contraceptive Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. GCC Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 115. GCC Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
TABLE 116. GCC Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 117. GCC Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
TABLE 118. GCC Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
TABLE 119. GCC Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 120. GCC Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 121. European Union Pet Contraceptive Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. European Union Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 123. European Union Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
TABLE 124. European Union Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 125. European Union Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
TABLE 126. European Union Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
TABLE 127. European Union Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 128. European Union Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 129. BRICS Pet Contraceptive Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. BRICS Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 131. BRICS Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
TABLE 132. BRICS Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 133. BRICS Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
TABLE 134. BRICS Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
TABLE 135. BRICS Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 136. BRICS Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 137. G7 Pet Contraceptive Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. G7 Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 139. G7 Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
TABLE 140. G7 Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 141. G7 Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
TABLE 142. G7 Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
TABLE 143. G7 Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 144. G7 Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. NATO Pet Contraceptive Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 146. NATO Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 147. NATO Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
TABLE 148. NATO Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 149. NATO Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
TABLE 150. NATO Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
TABLE 151. NATO Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 152. NATO Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 153. Global Pet Contraceptive Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 154. United States Pet Contraceptive Vaccine Market Size, 2017-2032 (USD Million)
TABLE 155. United States Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 156. United States Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
TABLE 157. United States Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 158. United States Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
TABLE 159. United States Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
TABLE 160. United States Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 161. United States Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 162. Canada Pet Contraceptive Vaccine Market Size, 2017-2032 (USD Million)
TABLE 163. Canada Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 164. Canada Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
TABLE 165. Canada Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 166. Canada Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
TABLE 167. Canada Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
TABLE 168. Canada Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 169. Canada Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 170. Mexico Pet Contraceptive Vaccine Market Size, 2017-2032 (USD Million)
TABLE 171. Mexico Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 172. Mexico Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
TABLE 173. Mexico Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 174. Mexico Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
TABLE 175. Mexico Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
TABLE 176. Mexico Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 177. Mexico Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. Brazil Pet Contraceptive Vaccine Market Size, 2017-2032 (USD Million)
TABLE 179. Brazil Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 180. Brazil Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
TABLE 181. Brazil Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 182. Brazil Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
TABLE 183. Brazil Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
TABLE 184. Brazil Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 185. Brazil Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 186. United Kingdom Pet Contraceptive Vaccine Market Size, 2017-2032 (USD Million)
TABLE 187. United Kingdom Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 188. United Kingdom Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
TABLE 189. United Kingdom Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 190. United Kingdom Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
TABLE 191. United Kingdom Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
TABLE 192. United Kingdom Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 193. United Kingdom Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 194. Germany Pet Contraceptive Vaccine Market Size, 2017-2032 (USD Million)
TABLE 195. Germany Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 196. Germany Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
TABLE 197. Germany Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 198. Germany Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
TABLE 199. Germany Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
TABLE 200. Germany Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 201. Germany Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 202. France Pet Contraceptive Vaccine Market Size, 2017-2032 (USD Million)
TABLE 203. France Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 204. France Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
TABLE 205. France Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 206. France Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
TABLE 207. France Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
TABLE 208. France Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 209. France Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 210. Russia Pet Contraceptive Vaccine Market Size, 2017-2032 (USD Million)
TABLE 211. Russia Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 212. Russia Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
TABLE 213. Russia Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 214. Russia Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
TABLE 215. Russia Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
TABLE 216. Russia Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 217. Russia Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 218. Italy Pet Contraceptive Vaccine Market Size, 2017-2032 (USD Million)
TABLE 219. Italy Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 220. Italy Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
TABLE 221. Italy Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 222. Italy Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
TABLE 223. Italy Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
TABLE 224. Italy Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 225. Italy Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 226. Spain Pet Contraceptive Vaccine Market Size, 2017-2032 (USD Million)
TABLE 227. Spain Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 228. Spain Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
TABLE 229. Spain Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 230. Spain Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
TABLE 231. Spain Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
TABLE 232. Spain Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 233. Spain Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 234. China Pet Contraceptive Vaccine Market Size, 2017-2032 (USD Million)
TABLE 235. China Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 236. China Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
TABLE 237. China Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 238. China Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
TABLE 239. China Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
TABLE 240. China Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 241. China Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 242. India Pet Contraceptive Vaccine Market Size, 2017-2032 (USD Million)
TABLE 243. India Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 244. India Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
TABLE 245. India Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 246. India Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
TABLE 247. India Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
TABLE 248. India Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 249. India Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 250. Japan Pet Contraceptive Vaccine Market Size, 2017-2032 (USD Million)
TABLE 251. Japan Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 252. Japan Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
TABLE 253. Japan Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 254. Japan Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
TABLE 255. Japan Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
TABLE 256. Japan Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 257. Japan Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 258. Australia Pet Contraceptive Vaccine Market Size, 2017-2032 (USD Million)
TABLE 259. Australia Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 260. Australia Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
TABLE 261. Australia Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 262. Australia Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
TABLE 263. Australia Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
TABLE 264. Australia Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 265. Australia Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 266. South Korea Pet Contraceptive Vaccine Market Size, 2017-2032 (USD Million)
TABLE 267. South Korea Pet Contraceptive Vaccine Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 268. South Korea Pet Contraceptive Vaccine Market Size, by Cats, 2017-2032 (USD Million)
TABLE 269. South Korea Pet Contraceptive Vaccine Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 270. South Korea Pet Contraceptive Vaccine Market Size, by Hormonal, 2017-2032 (USD Million)
TABLE 271. South Korea Pet Contraceptive Vaccine Market Size, by Non-Hormonal, 2017-2032 (USD Million)
TABLE 272. South Korea Pet Contraceptive Vaccine Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 273. South Korea Pet Contraceptive Vaccine Market Size, by End User, 2017-2032 (USD Million)
TABLE 274. Global Pet Contraceptive Vaccine Market Share, by Key Player, 2025
TABLE 275. Global Pet Contraceptive Vaccine Market, Key Experts

Companies Mentioned

  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale S.A.
  • Elanco Animal Health Incorporated
  • Hester Biosciences Limited
  • HIPRA, S.A.
  • Merck & Co., Inc.
  • SenesTech, Inc.
  • Vetoquinol S.A.
  • Virbac S.A.
  • Zoetis Inc.

Related Topics

Related Reports

Hormonal Contraceptives Market - Global Forecast 2026-2032 - Product Image

Hormonal Contraceptives Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Female Contraceptive Market - Global Forecast 2026-2032 - Product Image

Female Contraceptive Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Contraceptive Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Contraceptive Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Contraceptive Sponges - Global Strategic Business Report - Product Image

Contraceptive Sponges - Global Strategic Business Report

  • Report
  • 270 Pages
  • Global
From
Hormonal Contraceptive Market Report by Product, Hormone, Age Group, End User, and Region 2026-2034 - Product Image

Hormonal Contraceptive Market Report by Product, Hormone, Age Group, End User, and Region 2026-2034

  • Report
  • 144 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.